Back to Atlas
CTransientStandard research/education caution
CMP-0440
Approved antibiotic in some regions; senolytic use not approved
Roxithromycin
Senolytic-adjacent / Mitochondrial stress
Reported senolytic-adjacent activity in some models
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Macrolide antibiotic
- Primary mechanism
- Macrolide anti-inflammatory and mitochondrial effects
- Primary market use
- Anti-infective / senolytic research
Pharmacology
- Molecular weight (Da)
- 837.1
- Oral bioavailability
- Oral; high
- Half-life
- ~12 h
- Route tags
- Route-dependent / verify
- Evidence level
- Approved/Preclinical
- Clinical status
- Approved antibiotic in some regions; senolytic use not approved
- Value-for-money score
- 2 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Low-confidence senolytic; antibiotic stewardship limits value